OPT logo

Opthea Limited American Depositary Shares

OPT

OPT: Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.

more

Show OPT Financials

All
Government
Consumer Interest
SEC Filings
ESG/Other

Recent trades of OPT by members of U.S. Congress

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login

Recently reported changes by institutional investors

Quiver Logo

Sign Up for Access

Sign Up or Login

Quarterly net insider trading by OPT's directors and management

Quiver Logo

Sign Up for Access

Sign Up or Login

Government lobbying spending instances

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
U.S. Patents

New patents grants

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
Government Contracts

Federal grants, loans, and purchases

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
WallStreetBets

Number of mentions of OPT in WallStreetBets Daily Discussion

Quiver Logo

Sign Up for Access

Sign Up or Login
OPT News

Recent insights relating to OPT

  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
  • Patent Title: Hidden Quiver Patent Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
CNBC Recommendations

Recent picks made for OPT stock on CNBC

  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
  • Pick: Hidden Pick Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
Top ETF Holders

ETFs with the largest estimated holdings in OPT

  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
  • ETF: Hidden ETF Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login
Corporate Flights

Flights by private jets registered to OPT

  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
  • Flight Title: Hidden Quiver Flight Title Hidden Date
Quiver Logo

Sign Up for Access

Sign Up or Login